Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05681884 |
|
Recruitment Status :
Recruiting
First Posted : January 12, 2023
Last Update Posted : October 23, 2023
|
Sponsor:
Greater Houston Retina Research
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Greater Houston Retina Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | March 20, 2026 |
| Estimated Study Completion Date : | April 13, 2026 |